Literature DB >> 30273884

GxE effects of FKBP5 and traumatic life events on PTSD: A meta-analysis.

Sage E Hawn1, Christina M Sheerin2, Mackenzie J Lind2, Terrell A Hicks3, Marisa E Marraccini4, Kaitlin Bountress2, Silviu-Alin Bacanu2, Nicole R Nugent5, Ananda B Amstadter6.   

Abstract

BACKGROUND: Twin studies have demonstrated that both genetic and environmental factors influence risk for posttraumatic stress disorder (PTSD), and there is some evidence supporting the interplay of genes and environment (GxE). Many GxE studies within the PTSD literature have focused on genes implicated in the stress response system, such as FK506 binding protein 51 (FKBP5). Given inconsistencies across GxE literature as a whole, a meta-analysis to synthesize results is warranted.
METHODS: Studies were identified through PubMed and PsycINFO. A meta-analysis was conducted using a random effects model in the MAc package in R. Heterogeneity of the effect size distribution was examined with Cochran's Q statistic. A Simes procedure was used to test the gene-level GxE effect for FKBP5 interacting with trauma.
RESULTS: A significant gene-level GxE gene effect was demonstrated for FKBP5 when pooled across all four examined variants (rs1360780, rs3800373, rs9296158, rs9470080) when interacting with trauma exposure on PTSD. Significant large GxE effect sizes were also found for each independent variant. There was no evidence for heterogeneity of variance. LIMITATIONS: Limitations include reduced power for detecting variability across moderators, potential bias due to failure of meta-analyzed studies to account for two-way covariate x gene and covariate x environment influences, and a high false discovery rate that is characteristic of GxE analyses.
CONCLUSIONS: This is the first study to quantify an overall gene-level effect of FKBP5 in a GxE analysis of PTSD, evidence which may be used to address current issues in the FKBP5 GxE literature (e.g., disparate variants, low sample sizes and power), as well as inform follow-up functional research.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Alcohol; FKBP5; GxE; Posttraumatic stress; Trauma

Mesh:

Substances:

Year:  2018        PMID: 30273884      PMCID: PMC6487483          DOI: 10.1016/j.jad.2018.09.058

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Adverse childhood experiences, posttraumatic stress, and FKBP5 methylation patterns in postpartum women and their newborn infants.

Authors:  Damion J Grasso; Stacy Drury; Margaret Briggs-Gowan; Amy Johnson; Julian Ford; Garry Lapidus; Victoria Scranton; Christine Abreu; Jonathan Covault
Journal:  Psychoneuroendocrinology       Date:  2020-02-07       Impact factor: 4.905

Review 2.  MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans.

Authors:  Sudhiranjan Gupta; Rakeshwar S Guleria; Yvette Z Szabo
Journal:  Psychiatry Res       Date:  2021-10-26       Impact factor: 3.222

Review 3.  Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits.

Authors:  Kerry J Ressler; Sabina Berretta; Vadim Y Bolshakov; Isabelle M Rosso; Edward G Meloni; Scott L Rauch; William A Carlezon
Journal:  Nat Rev Neurol       Date:  2022-03-29       Impact factor: 44.711

4.  Meta-Analysis of Associations Between Hypothalamic-Pituitary-Adrenal Axis Genes and Risk of Posttraumatic Stress Disorder.

Authors:  Christina M Sheerin; Mackenzie J Lind; Kaitlin E Bountress; Marisa E Marraccini; Ananda B Amstadter; Silviu-Alin Bacanu; Nicole R Nugent
Journal:  J Trauma Stress       Date:  2020-03-26

5.  Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression.

Authors:  Stefan Wuchty; Amanda J Myers; Manuel Ramirez-Restrepo; Matthew Huentelman; Ryan Richolt; Felicia Gould; Philip D Harvey; Vasiliki Michopolous; Jennifer S Steven; Aliza P Wingo; Adriana Lori; Jessica L Maples-Keller; Alex O Rothbaum; Tanja Jovanovic; Barbara O Rothbaum; Kerry J Ressler; Charles B Nemeroff
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

6.  Associations between PTSD-Related extinction retention deficits in women and plasma steroids that modulate brain GABAA and NMDA receptor activity.

Authors:  Suzanne L Pineles; Yael I Nillni; Graziano Pinna; Andrea Webb; Kimberly A Arditte Hall; Jennifer R Fonda; John Irvine; Matthew W King; Richard L Hauger; Patricia A Resick; Scott P Orr; Ann M Rasmusson
Journal:  Neurobiol Stress       Date:  2020-05-15

7.  Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus.

Authors:  Tobias Wiechmann; Simone Röh; Susann Sauer; Darina Czamara; Janine Arloth; Maik Ködel; Madita Beintner; Lisanne Knop; Andreas Menke; Elisabeth B Binder; Nadine Provençal
Journal:  Clin Epigenetics       Date:  2019-05-23       Impact factor: 6.551

8.  Genetic and Environmental Predictors of Adolescent PTSD Symptom Trajectories Following a Natural Disaster.

Authors:  Christina M Sheerin; Laurel V Kovalchick; Cassie Overstreet; Lance M Rappaport; Vernell Williamson; Vladimir Vladimirov; Kenneth J Ruggiero; Ananda B Amstadter
Journal:  Brain Sci       Date:  2019-06-20

9.  Longitudinal genome-wide methylation study of PTSD treatment using prolonged exposure and hydrocortisone.

Authors:  Ruoting Yang; Changxin Xu; Linda M Bierer; Janine D Flory; Aarti Gautam; Heather N Bader; Amy Lehrner; Iouri Makotkine; Frank Desarnaud; Stacy A Miller; Marti Jett; Rasha Hammamieh; Rachel Yehuda
Journal:  Transl Psychiatry       Date:  2021-07-13       Impact factor: 6.222

10.  FKBP5 haplotypes and PTSD modulate the resting-state brain activity in Han Chinese adults who lost their only child.

Authors:  Rongfeng Qi; Yifeng Luo; Li Zhang; Yifei Weng; Wesley Surento; Neda Jahanshad; Qiang Xu; Yan Yin; Lingjiang Li; Zhihong Cao; Paul M Thompson; Guang Ming Lu
Journal:  Transl Psychiatry       Date:  2020-03-13       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.